← Back to Search

Photobiomodulation

OrthoPulse Light Therapy for Teeth Alignment

N/A
Recruiting
Led By Todd Dickerson
Research Sponsored by Biolux Technology GmbH
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 42 days after start of treatment
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a light therapy device called OrthoPulse to see if it can help people with braces move their teeth faster. The study focuses on patients who are currently using braces. OrthoPulse works by using light to speed up the activity of cells in the mouth, which helps teeth move more quickly.

Who is the study for?
This trial is for adults with 4-10mm crowding in lower front teeth, needing braces for Class I-III malocclusion. Candidates must not be institutionalized by order, dependent on the sponsor or site, have gaps in front teeth, need other oral devices during the study phase, have untreated cavities or missing teeth (except wisdom), be in another study or this one before, have a crossbite upfront, or be pregnant/planning pregnancy.
What is being tested?
The study tests OrthoPulse photobiomodulation's safety and effectiveness to speed up tooth movement with braces. Participants will either receive OrthoPulse treatment alongside regular orthodontic care or undergo standard treatment without additional interventions.
What are the potential side effects?
While specific side effects are not detailed here, photobiomodulation generally has minimal risks which may include mild discomfort at the application site. The procedure is non-invasive and considered safe.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~42 days after start of treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 42 days after start of treatment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
The primary endpoint of this PMCF study is the rate of tooth alignment.

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: OrthoPulseExperimental Treatment1 Intervention
The study population includes a total of 41 patients (based on our sample size calculation), with 21 patients in group 1 and 21 patients in group 2. Eligible study participants are men and women over the age of 18 with permanent dentition who require orthodontic treatment.
Group II: ControlActive Control1 Intervention
The study population includes a total of 41 patients (based on our sample size calculation), with 21 patients in group 1 and 21 patients in group 2. Eligible study participants are men and women over the age of 18 with permanent dentition who require orthodontic treatment.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Orthodontic treatments commonly involve the use of braces or aligners to apply continuous pressure on teeth, gradually moving them into the desired position. The mechanisms of action include bone remodeling, where osteoclasts break down bone tissue on the pressure side of the tooth and osteoblasts build up bone on the tension side. Photobiomodulation, such as that studied in the OrthoPulse trial, uses low-level laser therapy to accelerate tooth movement by enhancing cellular activity and reducing inflammation. Understanding these mechanisms is crucial for patients as it helps in selecting the most effective treatment, managing expectations, and improving overall treatment outcomes.

Find a Location

Who is running the clinical trial?

Biolux Technology GmbHLead Sponsor
medXteam GmbHOTHER
1 Previous Clinical Trials
2,183 Total Patients Enrolled
Todd DickersonPrincipal InvestigatorPrivate Practice 1200 W Warner Rd, Chandler, AZ 85224

Media Library

OrthoPulse (Photobiomodulation) Clinical Trial Eligibility Overview. Trial Name: NCT05650359 — N/A
Orthodontics Research Study Groups: Control, OrthoPulse
Orthodontics Clinical Trial 2023: OrthoPulse Highlights & Side Effects. Trial Name: NCT05650359 — N/A
OrthoPulse (Photobiomodulation) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05650359 — N/A
~25 spots leftby May 2028